D-0636-2021 Class II Terminated

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0636-2021 was initiated by Teligent Pharma, Inc. on May 14, 2021 and is designated Class II. Reason for recall: Presence of Foreign Substance: Foreign particles observed during routine stability testing. The recall status is terminated (terminated Aug 22, 2022). Affected quantity: 6,240 tubes.

Recall details

Product Type
Drugs
Report Date
Jun 30, 2021
Initiation Date
May 14, 2021
Termination Date
Aug 22, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,240 tubes

Product description

Diflorasone Diacetate Ointment USP, 0.05%, packaged in a)15 g (NDC 52565-063-15) and b) 30 g (NDC 52565-063-30) tubes, Rx only, Manufactured by: Teligent Pharma, Inc, Buena, NJ 08310.

Reason for recall

Presence of Foreign Substance: Foreign particles observed during routine stability testing.

Distribution pattern

Nationwide in the United States

Code information

Lot #: 16264, Exp Date Nov 2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0636-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0636-2021. Report a data issue: hello@regdatalab.com.